Last Close
Feb 03  •  12:43PM ET
338.25
Dollar change
-3.58
Percentage change
-1.05
%
Today, 9:47 AMRBC Capital downgrades Elevance Health to Sector Perform from Outperform and cuts price target to $358 on concern over softer-than-expected 2026 guidance and margin outlook.
IndexS&P 500 P/E13.47 EPS (ttm)25.11 Insider Own0.29% Shs Outstand222.24M Perf Week4.75%
Market Cap75.17B Forward P/E11.47 EPS next Y29.49 Insider Trans0.19% Shs Float221.59M Perf Month-4.52%
Enterprise Value- PEG2.24 EPS next Q10.57 Inst Own91.08% Short Float1.66% Perf Quarter6.64%
Income5.66B P/S0.38 EPS this Y-13.76% Inst Trans-2.32% Short Ratio2.28 Perf Half Y23.03%
Sales199.12B P/B1.71 EPS next Y12.89% ROA4.75% Short Interest3.69M Perf YTD-3.51%
Book/sh197.95 P/C- EPS next 5Y5.12% ROE13.29% 52W High458.75 -26.27% Perf Year-14.52%
Cash/sh- P/FCF23.68 EPS past 3/5Y1.27% 6.99% ROIC7.58% 52W Low273.71 23.58% Perf 3Y-31.32%
Dividend Est.7.11 (2.10%) EV/EBITDA- Sales past 3/5Y8.34% 10.32% Gross Margin- Volatility5.51% 3.30% Perf 5Y16.57%
Dividend TTM6.84 (2.02%) EV/Sales- EPS Y/Y TTM-11.11% Oper. Margin4.07% ATR (14)12.40 Perf 10Y145.54%
Dividend Ex-DateMar 10, 2026 Quick Ratio- Sales Y/Y TTM12.62% Profit Margin2.84% RSI (14)41.51 Recom2.08
Dividend Gr. 3/5Y10.14% 12.47% Current Ratio1.54 EPS Q/Q36.35% SMA20-6.76% Beta0.50 Target Price382.70
Payout27.13% Debt/Eq0.73 Sales Q/Q9.47% SMA50-3.36% Rel Volume0.40 Prev Close341.83
Employees104200 LT Debt/Eq0.70 EarningsJan 28 BMO SMA200-2.27% Avg Volume1.61M Price338.25
IPOOct 30, 2001 Option/ShortYes / Yes EPS/Sales Surpr.7.54% -1.07% Trades Volume338,197 Change-1.05%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade RBC Capital Mkts Outperform → Sector Perform $358
Jan-08-26Upgrade Wolfe Research Peer Perform → Outperform $425
Dec-19-25Downgrade Deutsche Bank Buy → Hold $320
Oct-14-25Initiated Goldman Neutral
Jul-21-25Downgrade Argus Buy → Hold
Jul-18-25Downgrade Leerink Partners Outperform → Market Perform $310
Apr-15-25Downgrade Robert W. Baird Outperform → Neutral $529
Mar-17-25Upgrade Argus Hold → Buy $450
Jan-22-25Downgrade Stephens Overweight → Equal-Weight $520 → $440
Oct-18-24Downgrade Argus Buy → Hold
Today 09:34AM
03:08AM
Feb-02-26 11:18AM
10:47AM
Jan-31-26 07:48AM
02:44PM Loading…
Jan-29-26 02:44PM
09:13AM
02:19AM
12:37AM
Jan-28-26 04:32PM
04:02PM
01:35PM
01:01PM
12:35PM
12:21PM
11:15AM Loading…
11:15AM
10:20AM
10:09AM
10:06AM
09:30AM
07:42AM
07:10AM
06:41AM
06:26AM
06:17AM
06:00AM
Jan-27-26 05:33PM
05:12PM
04:54PM
04:44PM
04:44PM Loading…
04:44PM
04:38PM
04:34PM
04:17PM
04:13PM
03:27PM
12:55PM
12:44PM
11:55AM
11:42AM
11:41AM
11:15AM
10:35AM
10:07AM
09:55AM
07:17AM
07:16AM
12:09AM
12:09AM
Jan-26-26 10:19PM
10:09PM
08:20AM
Jan-25-26 12:39PM
07:52AM
Jan-24-26 09:00AM
Jan-23-26 05:25PM
04:42PM
09:15AM
Jan-22-26 12:27PM
06:58AM
Jan-21-26 11:21AM
10:00AM
08:30AM
Jan-20-26 11:05PM
Jan-19-26 09:33AM
07:38AM
Jan-16-26 10:47AM
Jan-15-26 12:14PM
12:04PM
08:00AM
Jan-14-26 12:53PM
Jan-13-26 08:49AM
Jan-12-26 11:33PM
Jan-11-26 11:03AM
Jan-08-26 01:13PM
11:35AM
07:55AM
Jan-06-26 11:04AM
Jan-05-26 11:08AM
09:11AM
Dec-30-25 12:15PM
Dec-29-25 11:59PM
Dec-26-25 11:26AM
Dec-23-25 08:37AM
Dec-22-25 04:30PM
Dec-19-25 04:58PM
10:00AM
09:43AM
08:45AM
Dec-18-25 05:33PM
05:11PM
Dec-17-25 09:10AM
08:11AM
Dec-15-25 10:37PM
Dec-12-25 02:00PM
11:10AM
Dec-11-25 01:08PM
03:45AM
Dec-10-25 04:30PM
11:02AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeVore Susan D.DirectorAug 19 '25Buy312.151,200374,5803,502Aug 21 04:20 PM
BOUDREAUX GAILPresident and CEOJul 18 '25Buy286.948,5002,438,951151,020Jul 18 01:42 PM
Kaye MarkEVP & CFOApr 24 '25Sale424.824,5881,949,07418,977Apr 25 04:17 PM
Kaye MarkOfficerApr 24 '25Proposed Sale424.814,5881,949,051Apr 24 05:10 PM
Penczek Ronald WCAO & ControllerMar 10 '25Sale415.13443183,9031,847Mar 11 04:20 PM
Penczek Ronald WOfficerMar 10 '25Proposed Sale415.13443183,904Mar 10 02:55 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 05 '25Sale396.303,5041,388,63510,116Mar 05 05:52 PM
Kendrick Charles Morgan JROfficerMar 05 '25Proposed Sale396.303,5041,388,651Mar 05 05:19 PM